US equities
|
MU
$992.23
▼-3.57%
META
$746.55
▲+3.88%
NVDA
$226.53
▼-1.20%
SNDK
$1,479.46
▼-6.47%
SPCX
$164.38
▲+1.11%
AMD
$590.37
▼-2.92%
MSFT
$539.91
▲+0.90%
TSLA
$379.26
▼-0.90%
MU
$992.23
▼-3.57%
META
$746.55
▲+3.88%
NVDA
$226.53
▼-1.20%
SNDK
$1,479.46
▼-6.47%
SPCX
$164.38
▲+1.11%
AMD
$590.37
▼-2.92%
MSFT
$539.91
▲+0.90%
TSLA
$379.26
▼-0.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
CervoMed Inc. - Common Stock
(NQ:
CRVO
)
2.499
-0.721 (-22.39%)
Delayed Quote
Updated: 2:11 PM EDT, Oct 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about CervoMed Inc. - Common Stock
CervoMed’s neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral Sclerosis
February 18, 2026
From
CervoMed Inc.
Via
GlobeNewswire
Peraso (NASDAQ: PRSO) Powers Military, Nex-Gen Broadband Surge – Mag 7 Undercard VAPE CELC, CRVO – More Stocks Inside
July 28, 2025
Via
AB Newswire
Topics
Supply Chain